Search results

This gap up was good enough. I cut back to a bit under 2% position. I think thats conservative but its a complex company that requires a lot of work, so I can't justify being all agressive

Gonna let this thing squeeze shorts a bit then lighten up some

I'm likely to reduce my VRX today if the stock opens up. I'm finding myself taking too much time of my day to research this stuff again. If I take this down from 4% to 2%, I believe I will be able to ignore the noise and hold it more. Its a very volatile stock anyway, so its probably more...

You are correct. In this type of situation (1 cent spread) is frequently better to hit the spread. There is an alternative, that is to use a inverted exchange/ECN to get filled BEFORE the guys sitting at $10. Places like EDGA, Boston, BYX offer a financial incentive for people to hit them (no...

Another thing with VRX is that because I'm a day trader, if some news comes out intraday (or even when the markets are closed), I'm likely to short the stock as a hedge or even take a directional short on it. So this makes the stock a bit less risky to me because I can protect myself if things...

I'm all for short-term trading the stock in both directions. In fact, I played both sides today as a daytrade today. Unfortunately the scoundrel citron released his bs right when the stock did an opening range breakout and that shook me out of a day trade long. But I got no issue with this sort...

If anything, the outcry against that shows that the strategy is not sustainable. There is the loss of brand value associated with the strategy (which can be calculated down to a monetary value). That loss of brand value (both of the company and its products) and popularity is an extra cost...

Munger is a great investor, however, ins't the success of Berkshire, according to Buffett, largely been driven by buying companies with big moats who have pricing power? So by definition they want companies who can raise prices more than their competitors. As I said before, if someone have...

The NYT pieces bashing VRX were taking one or 2 drugs out of a huge portfolio, looking at gross price increases and generalizing the entire company based on that. thats a mistake

I question how much work has had done analysing the company. I bet he is making the mistake of confusing gross price increase with net price increase. Net price increases were much lower than gross

So i got in with a 4% position between VRX and PSH. Will save the last 1% until there is a flush or some kind of positive catalyst. I wouldn't recommend people to get in, unless they do their homework and due dilligence. The company is very unpopular and this leads to a media frenzy that doesn't...

There are some risks. I'm not 100% sure the stock is a great buy but I'm 70-80% sure. I certainly not seeing anything the shorts are putting out as relevant. I exchange some emails with Hempton over the weekend and everything he put out was weak. He changed this thesis (because Ackman burried...

Citron is backing out of his BS according to the WSJ. I started in pre-market here on VRX. Will go all the way to a 5% position

1. That's possible, but when a stock is in a panic people will get emotional and overestimate that chance of that happening. Furthermore a lawsuit that is not settled (your scenario) is likely to take even longer than one with a settlement (due appeals, etc). So we are talking about 4-5 years in...

Check out Ackman's presentation. at $93 there is already a lot of value I don't know how low it will drop. People are dumping because of fear, career risk (you don't want to be caught holding something that people are calling an enron), momentum etc. It probably won't go bellow $80 for very long...

they also have a diversified business mix, you got many categories being 15-20% of revenues.

if you look at the ackman presentation, the media has gottan VRX all wrong. the strategy the depends on price hikes is not a sigificant part of the business. going forward the company is not even planning to use that much more. furthermore, the stock, at $93, is a buy even with no growth. it...

I wouldn't recommend doing what you suggest (two orders to buy 100 shares each if you only want 100 shares), you might get overfilled and then you will have to sell 100 shares and pay commissions/be exposed to market changes. Same thing on the sell side, you CAN send 2 orders to sell 100 shares...

The largest healthcare settlement in history is $3B. Valeant can afford that. The stuff they did is not even close to as bad as what other companies did. You don't get the impression from twitter and the media beause the issue has been blown out of proportion. You would think they were running...

Even for long-term I think the bonds are an interesting idea. Ackman has historically made 20% a year versus 8% of the S&P500. So, double plus a little bit. With US stocks richly valued, most 10 year forecasts are running around 3-5% a year for the next 10 years. Double plus a bit would be...